Regulators are changing the way they look at labeling. Their focus has expanded beyond the traditional pharmacovigilance scope. Regulators now expect the industry to deliver accurate and timely labeling information and risk minimization activities, all the way to patients and healthcare professionals.
Labeling Assessment ExpressTM is a highly cost-effective diagnostic approach which provides a rapid analysis of the health of an E2E labeling system, in as little as a week. Navitas Life Sciences has developed Labeling Assessment ExpressTM using its extensive experience and insight, gained through a long history of E2E labeling improvement projects and its industry leading best practice forum, labelnet.